TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis

被引:249
作者
Oldham, Justin M. [1 ]
Ma, Shwu-Fan [1 ]
Martinez, Fernando J. [2 ]
Anstrom, Kevin J. [3 ]
Raghu, Ganesh [4 ]
Schwartz, David A. [5 ]
Valenzi, Eleanor [1 ]
Witt, Leah [1 ]
Lee, Cathryn [1 ]
Vij, Rekha [1 ]
Huang, Yong [1 ]
Strek, Mary E. [1 ]
Noth, Imre [1 ]
机构
[1] Univ Chicago, Sect Pulm & Crit Care Med, Dept Med, Chicago, IL 60637 USA
[2] Weill Cornell Med Sch, Dept Internal Med, New York, NY USA
[3] Duke Univ, Duke Clin Res Inst, Durham, NC USA
[4] Univ Washington, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA
[5] Univ Colorado, Dept Med, Denver, CO USA
基金
美国国家卫生研究院;
关键词
IPF; pharmacogenetics; N-acetylcysteine; drug-gene interaction; host defense; PROMOTER POLYMORPHISM; LUNG INJURY; END-POINTS; ASSOCIATION; SUSCEPTIBILITY; TOLL-LIKE-RECEPTOR-4; IDENTIFICATION; PROGRESSION; EXPRESSION; EXPOSURE;
D O I
10.1164/rccm.201505-1010OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease of unknown etiology. The genes TOLLIP and MUC5B play important roles in lung host defense, which is an immune process influenced by oxidative signaling. Whether polymorphisms in TOLLIP and MUC5B modify the effect of immunosuppressive and antioxidant therapy in individuals with IPF is unknown. Objectives: To determine whether single-nucleotide polymorphisms (SNPs) within TOLLIP and MUC5B modify the effect of interventions in subjects participating in the Evaluating the Effectiveness of Prednisone, Azathioprine, and N-Acetylcysteine in Patients with Idiopathic Pulmonary Fibrosis (PANTHER-IPF) clinical trial. Methods: SNPs within TOLLIP (rs5743890/rs5743894/rs5743854/rs3750920) and MUC5B (rs35705950) were genotyped. Interaction modeling was conducted with multivariable Cox regression followed by genotype-stratified survival analysis using a composite endpoint of death, transplantation, hospitalization, or a decline of >= 10% in FVC. Measurements and Main Results: Significant interaction was observed between N-acetylcysteine (NAC) therapy and rs3750920 within TOLLIP (P-interaction = 0.001). After stratifying by rs3750920 genotype, NAC therapy was associated with a significant reduction in composite endpoint risk (hazard ratio, 0.14; 95% confidence interval, 0.02-0.83; P = 0.03) in those with a TT genotype, but a nonsignificant increase in composite endpoint risk (hazard ratio, 3.23; 95% confidence interval, 0.79-13.16; P = 0.10) was seen in those with a CC genotype. These findings were then replicated in an independent IPF cohort. Conclusions: NAC may be an efficacious therapy for individuals with IPF with an rs3750920 (TOLLIP) TT genotype, but it was associated with a trend toward harm in those with a CC genotype. A genotype-stratified prospective clinical trial should be conducted before any recommendation regarding the use of off-label NAC to treat IPF.
引用
收藏
页码:1475 / 1482
页数:8
相关论文
共 39 条
[1]   An integrated map of genetic variation from 1,092 human genomes [J].
Altshuler, David M. ;
Durbin, Richard M. ;
Abecasis, Goncalo R. ;
Bentley, David R. ;
Chakravarti, Aravinda ;
Clark, Andrew G. ;
Donnelly, Peter ;
Eichler, Evan E. ;
Flicek, Paul ;
Gabriel, Stacey B. ;
Gibbs, Richard A. ;
Green, Eric D. ;
Hurles, Matthew E. ;
Knoppers, Bartha M. ;
Korbel, Jan O. ;
Lander, Eric S. ;
Lee, Charles ;
Lehrach, Hans ;
Mardis, Elaine R. ;
Marth, Gabor T. ;
McVean, Gil A. ;
Nickerson, Deborah A. ;
Schmidt, Jeanette P. ;
Sherry, Stephen T. ;
Wang, Jun ;
Wilson, Richard K. ;
Gibbs, Richard A. ;
Dinh, Huyen ;
Kovar, Christie ;
Lee, Sandra ;
Lewis, Lora ;
Muzny, Donna ;
Reid, Jeff ;
Wang, Min ;
Wang, Jun ;
Fang, Xiaodong ;
Guo, Xiaosen ;
Jian, Min ;
Jiang, Hui ;
Jin, Xin ;
Li, Guoqing ;
Li, Jingxiang ;
Li, Yingrui ;
Li, Zhuo ;
Liu, Xiao ;
Lu, Yao ;
Ma, Xuedi ;
Su, Zhe ;
Tai, Shuaishuai ;
Tang, Meifang .
NATURE, 2012, 491 (7422) :56-65
[2]   Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB [J].
Asehnoune, K ;
Strassheim, D ;
Mitra, S ;
Kim, JY ;
Abraham, E .
JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :2522-2529
[3]   Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry [J].
Behr, Juergen ;
Kreuter, Michael ;
Hoeper, Marius M. ;
Wirtz, Hubert ;
Klotsche, Jens ;
Koschel, Dirk ;
Andreas, Stefan ;
Claussen, Martin ;
Grohe, Christian ;
Wilkens, Henrike ;
Randerath, Winfried ;
Skowasch, Dirk ;
Meyer, F. Joachim ;
Kirschner, Joachim ;
Glaeser, Sven ;
Herth, Felix J. F. ;
Welte, Tobias ;
Huber, Rudolf Maria ;
Neurohr, Claus ;
Schwaiblmair, Martin ;
Kohlhaeufl, Martin ;
Hoeffken, Gert ;
Held, Matthias ;
Koch, Andrea ;
Bahmer, Thomas ;
Pittrow, David .
EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (01) :186-196
[4]   Study Design Implications of Death and Hospitalization as End Points in Idiopathic Pulmonary Fibrosis [J].
Collard, Harold R. ;
Brown, Kevin K. ;
Martinez, Fernando J. ;
Raghu, Ganesh ;
Roberts, Rhonda S. ;
Anstrom, Kevin J. .
CHEST, 2014, 146 (05) :1256-1262
[5]   Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment [J].
DeFlora, S ;
Grassi, C ;
Carati, L .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (07) :1535-1541
[6]   Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials [J].
Durheim, Michael T. ;
Collard, Harold R. ;
Roberts, Rhonda S. ;
Brown, Kevin K. ;
Flaherty, Kevin R. ;
King, Talmadge E., Jr. ;
Palmer, Scott M. ;
Raghu, Ganesh ;
Snyder, Laurie D. ;
Anstrom, Kevin J. ;
Martinez, Fernando J. .
LANCET RESPIRATORY MEDICINE, 2015, 3 (05) :388-396
[7]   Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis [J].
Fingerlin, Tasha E. ;
Murphy, Elissa ;
Zhang, Weiming ;
Peljto, Anna L. ;
Brown, Kevin K. ;
Steele, Mark P. ;
Loyd, James E. ;
Cosgrove, Gregory P. ;
Lynch, David ;
Groshong, Steve ;
Collard, Harold R. ;
Wolters, Paul J. ;
Bradford, Williamson Z. ;
Kossen, Karl ;
Seiwert, Scott D. ;
du Bois, Roland M. ;
Garcia, Christine Kim ;
Devine, Megan S. ;
Gudmundsson, Gunnar ;
Isaksson, Helgi J. ;
Kaminski, Naftali ;
Zhang, Yingze ;
Gibson, Kevin F. ;
Lancaster, Lisa H. ;
Cogan, Joy D. ;
Mason, Wendi R. ;
Maher, Toby M. ;
Molyneaux, Philip L. ;
Wells, Athol U. ;
Moffatt, Miriam F. ;
Selman, Moises ;
Pardo, Annie ;
Kim, Dong Soon ;
Crapo, James D. ;
Make, Barry J. ;
Regan, Elizabeth A. ;
Walek, Dinesha S. ;
Daniel, Jerry J. ;
Kamatani, Yoichiro ;
Zelenika, Diana ;
Smith, Keith ;
McKean, David ;
Pedersen, Brent S. ;
Talbert, Janet ;
Kidd, Raven N. ;
Markin, Cheryl R. ;
Beckman, Kenneth B. ;
Lathrop, Mark ;
Schwarz, Marvin I. ;
Schwartz, David A. .
NATURE GENETICS, 2013, 45 (06) :613-+
[8]   Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study [J].
Han, MeiLan K. ;
Zhou, Yueren ;
Murray, Susan ;
Tayob, Nabihah ;
Noth, Imre ;
Lama, Vibha N. ;
Moore, Bethany B. ;
White, Eric S. ;
Flaherty, Kevin R. ;
Huffnagle, Gary B. ;
Martinez, Fernando J. .
LANCET RESPIRATORY MEDICINE, 2014, 2 (07) :548-556
[9]   Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis [J].
Hubbard, R ;
Lewis, S ;
Richards, K ;
Johnston, I ;
Britton, J .
LANCET, 1996, 347 (8997) :284-289
[10]   Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury [J].
Imai, Yumiko ;
Kuba, Keiji ;
Neely, G. Greg ;
Yaghubian-Malhami, Rubina ;
Perkmann, Thomas ;
van Loo, Geert ;
Ermolaeva, Maria ;
Veldhuizen, Ruud ;
Leung, Y. H. Connie ;
Wang, Hongliang ;
Liu, Haolin ;
Sun, Yang ;
Pasparakis, Manolis ;
Kopf, Manfred ;
Mech, Christin ;
Bavari, Sina ;
Peiris, J. S. Malik ;
Slutsky, Arthur S. ;
Akira, Shizuo ;
Hultqvist, Malin ;
Holmdahl, Rikard ;
Nicholls, John ;
Jiang, Chengyu ;
Binder, Christoph J. ;
Penninger, Josef M. .
CELL, 2008, 133 (02) :235-249